Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Liver metastases (LM) are common in various types of malignant diseases, either at the diagnosis of the primary tumour or at a later time point. While the resection of colorectal LM (CRLM) is a well-established procedure, with survival rates superior to chemotherapy alone, controversial data still exist on liver resection for non-colorectal LM (NCRLM) (2, 3). These patients comprise a diverse and heterogeneous group usually excluded from surgery due to advanced tumour stage or the presence of concomitant extrahepatic disease. To date, no randomized clinical trial on the surgical treatment of NCRLM has been conducted, and only few retrospective reports are available.The scope of this research project is to develop a large registry of patients undergoing liver surgery for non-colorectal liver metastases.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| liver resection | Procedure | Resection of non-colorectal liver metastases |
|
| Measure | Description | Time Frame |
|---|---|---|
| Overall Survival | Overall Survival defined as the time elapsed between the date of resective surgery and the date of death for any reason. Patients who are surviving at the end of observation will be considered "censored" at the date of the last available follow-up. | From date of enrollment until the date of death from any cause assessed up to 36 months |
| Measure | Description | Time Frame |
|---|---|---|
| Disease-free Survival | Disease-free Survival defined as the time from resective surgery to the date of first relapse or last available follow-up, whichever occurs first | From date of enrollement until the date of first documented progression assessed up to 36 months |
Not provided
Inclusion criteria:
Exclusion criteria
Not provided
Not provided
Not provided
All patients with a diagnosis, based on imaging methods and histologically confirmed, of NCRLM, consecutively referred to centres with expertise in hepatobiliary surgery will be evaluated for inclusion. For the diagnosis and staging of disease the participating centres will refer to the guidelines for NCRLM, together with the established clinical habits present in each centre
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Matteo Donadon, MD, PhD | Contact | 003903213733045 | matteo.donadon@uniupo.it |
| Name | Affiliation | Role |
|---|---|---|
| Matteo Donadon, MD, PhD | AOU della Carità , Novara, Italy | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006498 | Hepatectomy |
| ID | Term |
|---|---|
| D013505 | Digestive System Surgical Procedures |
| D013514 | Surgical Procedures, Operative |
Not provided
Not provided
Not provided
Not provided
Not provided